Connolly, Stuart J; Wallentin, Lars; Ezekowitz, Michael D; Eikelboom, John; Oldgren, Jonas; Reilly, Paul A; Brueckmann, Martina; Pogue, Janice; Alings, Marco; Amerena, John V; Avezum, Alvaro; Baumgartner, Iris; Budaj, Andrzej J; Chen, Jyh-Hong; Dans, Antonio L; Darius, Harald; Di Pasquale, Giuseppe; Ferreira, Jorge; Flaker, Greg C; Flather, Marcus D; ... (2013). The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation, 128(3), pp. 237-43. Baltimore, Md.: Lippincott Williams & Wilkins 10.1161/CIRCULATIONAHA.112.001139
Full text not available from this repository.During follow-up of between 1 and 3 years in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial, 2 doses of dabigatran etexilate were shown to be effective and safe for the prevention of stroke or systemic embolism in patients with atrial fibrillation. There is a need for longer-term follow-up of patients on dabigatran and for further data comparing the 2 dabigatran doses.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology |
UniBE Contributor: |
Baumgartner, Iris |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0009-7322 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:41 |
Last Modified: |
05 Dec 2022 14:13 |
Publisher DOI: |
10.1161/CIRCULATIONAHA.112.001139 |
PubMed ID: |
23770747 |
Web of Science ID: |
000321897400018 |
URI: |
https://boris.unibe.ch/id/eprint/17018 (FactScience: 224736) |
Actions (login required)
 |
Edit item |